Fundz

NexTel Medical to acquire JumpstartRx and NueVistraMed

PUBLIC · MAJIJun 04, 2026

Acquiring Company

NexTel Medical

Acquired Company

JumpstartRx

OrlandoBiotechnologyHealth CareMedicalBiotechnologyHealth CareMedical

Description

NexTel Medical Corp. announced its execution of Definitive Purchase Agreements to acquire JumpstartRx and NueVistraMed, enhancing its telehealth offerings. The transaction is valued at $8 million and will provide immediate revenue growth. The final closing is expected within 60 to 75 days, with significant operational synergies anticipated. This acquisition marks a strategic move toward expanding NexTel's portfolio in the wellness industry.

Quick answer

NexTel Medical is acquiring JumpstartRx, announced June 2, 2026. NexTel Medical is based in Orlando, Florida, United States.

How much did NexTel Medical pay for JumpstartRx?
The deal value was not disclosed.
What does NexTel Medical do?
NexTel Medical Corp. is a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems.
Where are NexTel Medical and JumpstartRx based?
NexTel Medical is based in Orlando, Florida, United States.

Source: Fundz verified event record.

Other recent acquisitions in Medical and Medical

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at NexTel Medical, and when

When NexTel Medical changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day NexTel Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NexTel Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NexTel Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NexTel Medical

Location

Orlando, Florida, United States

About

NexTel Medical Corp. is a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems. The company focuses on innovative healthcare solutions and enhances patient outcomes through advanced technologies. Its product line includes various therapeutic offerings aimed at improving medical efficiency and affordability. NexTel is committed to expanding its reach in the telehealth industry.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NexTel Medical makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for NexTel Medical's next move

Learn about Strategic plan

Frequently asked

Who acquired JumpstartRx?

JumpstartRx was acquired by NexTel Medical, based in Orlando. The deal was reported on June 4, 2026. NexTel Medical Corp. is a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems. NexTel Medical is publicly traded (MAJI) and operates in Biotechnology.

When did NexTel Medical acquire JumpstartRx?

NexTel Medical's acquisition of JumpstartRx was reported on June 4, 2026. NexTel Medical Corp. announced its execution of Definitive Purchase Agreements to acquire JumpstartRx and NueVistraMed, enhancing its telehealth offerings. The transaction is valued at $8 million and will provide immediate revenue growth. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does JumpstartRx do?

JumpstartRx is an innovative, direct-to-consumer telehealth platform offering clinical solutions with a focus on patient-centered care. The company aims to improve healthcare access and outcomes through advanced technology and distribution channels. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.